News
Public · Published
Xanadu Quantum Technologies Limited Stock 12‑Month Price Target Cut to $21.15, Implies 655% Upside
Analysts' average 12-month price target for Xanadu Quantum Technologies Limited fell from $23.75 to $21.15, while their forecasts range from $3.75 to $43 per share. Based on the Nov. 11 closing price, the new target implies about 655% potential upside. The consensus rating remains Buy.
Published:
Updated:
What happened
Analysts’ average 12-month price target for Xanadu Quantum Technologies Limited fell from $23.75 to $21.15, while their forecasts range from $3.75 to $43 per share. Based on the Nov. 11 closing price, the new target implies about 655% potential upside. The consensus rating remains Buy.
Confirmed
Global impact / market context
The lower average target signals that analysts have reduced their expectations, even though the stated target still implies substantial upside from the Nov. 11 close. These are forecasts, not guaranteed returns; they do not establish the company’s future sales, costs, cash available, or share value.
Analyst inference
The five analysts’ views are widely spread, from $3.75 to $43 per share, so the average masks substantial disagreement. Four rate the stock Buy and one Hold, with no Sell ratings; this small group’s consensus may not represent broader investor expectations.
Analyst inference
What to watch
- Watch for later analyst target revisions and rating changes: the supplied figures show a reduction in the average target, but do not explain why analysts changed their forecasts. Analyst inference
- Compare future company disclosures with the assumptions behind analysts’ forecasts, especially information that could change expected revenue, costs, or the need for capital spending. Analyst inference
- The current consensus is based on five covering analysts: four Buys, one Hold, and no Sells, while forecasts span $3.75 to $43 per share. Confirmed
Evidence
- Original source link unavailable